These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26894921)

  • 1. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
    Berger GE; Smesny S; Schäfer MR; Milleit B; Langbein K; Hipler UC; Milleit C; Klier CM; Schlögelhofer M; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
    PLoS One; 2016; 11(2):e0148429. PubMed ID: 26894921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niacin skin flush test: a research tool for studying schizophrenia.
    Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
    Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
    Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
    Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of olfactory identification ability in ultra-high risk for psychosis and drug-naïve first episode psychosis.
    Ouyang L; Ma X; Yuan L; Fan L; Liao A; Li D; Yang Z; Zhang Z; Liu W; Chen X; Li Z; He Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111035. PubMed ID: 38795823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis.
    Kim SW; Schäfer MR; Klier CM; Berk M; Rice S; Allott K; Bartholomeusz CF; Whittle SL; Pilioussis E; Pantelis C; McGorry PD; Amminger GP
    Schizophr Res; 2014 Sep; 158(1-3):39-44. PubMed ID: 25066495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
    Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
    Pawełczyk T; Trafalska E; Pawełczyk A; Kotlicka-Antczak M
    Early Interv Psychiatry; 2017 Dec; 11(6):498-508. PubMed ID: 26279283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders.
    Takahashi T; Wood SJ; Yung AR; Nelson B; Lin A; Yücel M; Phillips LJ; Nakamura Y; Suzuki M; Brewer WJ; Proffitt TM; McGorry PD; Velakoulis D; Pantelis C
    Schizophr Res; 2014 Mar; 153(1-3):18-24. PubMed ID: 24530137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased PLA
    Talib LL; Costa AC; Joaquim HPG; Pereira CAC; Van de Bilt MT; Loch AA; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1593-1599. PubMed ID: 33677687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EEG microstates as biomarker for psychosis in ultra-high-risk patients.
    de Bock R; Mackintosh AJ; Maier F; Borgwardt S; Riecher-Rössler A; Andreou C
    Transl Psychiatry; 2020 Aug; 10(1):300. PubMed ID: 32839449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
    Smesny S; Rosburg T; Riemann S; Baur K; Rudolph N; Berger G; Sauer H
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):393-402. PubMed ID: 15885994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.